C07K 16/1228
Enterobacterales
Official title: Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
C07K16/1228 (Enterobacterales) appears on 321 US grants and 422 published applications in this corpus.
Search patents in C07K- Granted patents
- 321
- Published applications
- 422
- Assignees
- 261
- Inventors
- 786
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 2 |
| 2002 | 3 | 8 |
| 2003 | 8 | 15 |
| 2004 | 1 | 14 |
| 2005 | 6 | 12 |
| 2006 | 5 | 12 |
| 2007 | 8 | 17 |
| 2008 | 11 | 8 |
| 2009 | 5 | 14 |
| 2010 | 6 | 12 |
| 2011 | 6 | 19 |
| 2012 | 8 | 12 |
| 2013 | 7 | 13 |
| 2014 | 17 | 25 |
| 2015 | 18 | 19 |
| 2016 | 16 | 28 |
| 2017 | 14 | 19 |
| 2018 | 16 | 26 |
| 2019 | 15 | 17 |
| 2020 | 17 | 18 |
| 2021 | 19 | 30 |
| 2022 | 14 | 16 |
| 2023 | 8 | 14 |
| 2024 | 19 | 22 |
| 2025 | 18 | 21 |
| 2026 | 1 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Compositions and methods for the treatment of immunodeficiency18 Nov 2025US 12,473,351 B2Adma Biomanufacturing, LLC
- Apparatus and method for detecting microbial contamination4 Nov 2025US 12,461,100 B2S D Systems, Inc.
- Pathogen binding proteins14 Oct 2025US 12,441,783 B2Bactolife APS
- Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft- versus-host disease7 Oct 2025US 12,435,125 B2Prodigy Biotech
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Anti-etec adhesin protein antibodies and methods of use17 Sep 2026US 2026/0274929 A1University of Massachusetts
- Antibodies against multidrug-resistant klebsiella pneumoniae6 Aug 2026US 2026/0226141 A1Fondazione Toscana Life Sciences
- E. coli fimh mutants and uses thereof7 May 2026US 2026/0124286 A1Pfizer Inc.
- Method and reagents for ultrasensitive immunoassay19 Mar 2026US 2026/0079158 A1Agri-Analysis, LLC
Most cited
By later US patents
- Transgenic plants expressing assembled secretory antibodies319US 5,959,177 AThe Scripps Research Institute · 1999
- Transgenic plants expressing assembled secretory antibodies273US 6,417,429 B1The Scripps Research Institute · 2002
- High affinity human antibodies and human antibodies against digoxin211US 6,255,458 B1GenPharm International, Inc. · 2001
- Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli104US 8,758,764 B2J. Craig Venter Institute, Inc. · 2014
- Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens96US 6,033,864 AThe Regents of the University of California · 2000